Biocytogen (HKEX: 02315) is excited to attend Bio-Europe 2024 in Stockholm, Sweden, from November 4-6!

Our Business Development Team is excited to meet you in person at Booth #74! Schedule a 1-on-1 meeting with us, and stop by to discover our innovative solutions in antibody drug discovery!

RenBiologics - Our fully human library. Your pipeline.

• Developed using our proprietary RenMice® fully human antibody discovery platform.
• Supports the development of monoclonal antibodies (mAbs), bispecific antibodies (bsAbs), bispecific ADCs (bsADCs), nanobodies, and TCR-mimic antibodies.
• Offers various collaboration models, including antibody licensing, transfer, and co-development.

Key Milestones:

• Created a fully human antibody library targeting 1,000+ targets.
• Established a library of 400k - 500k off-the-shelf, fully human antibody sequences.
• Formed 150+ collaborations.

Selected antibody assets from Biocytogen’s RenMice® platform:

Interested in exploring partnership opportunities? Schedule a 1-on-1 meeting with us or reach out for more details!